Back to Results

Carlsmed Inc (CARL)

Featured in High-Momentum Stocks High-Beta Momentum

Carlsmed, Inc. is a commercial-stage medical technology company focused on AI-enabled personalized solutions for spine surgery. The company designs, manufactures, and markets the aprevo platform for spine fusion procedures. Its system combines surgical planning software that uses outcomes-based algorithms supported by artificial intelligence with custom-built vertebral interbody implants designed to match patient anatomy. Carlsmed was incorporated in 2018 and is based in Carlsbad, California. Its common stock is listed on the NASDAQ under the symbol CARL.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-CARL
$12.06
-21.3% Downside
Overvalued
$19.40
26.6% Upside
Undervalued
Good
0.0%
November 10, 2026
5.0x
6.6x
418.3 M
351 M
5.1%
57.3%
6.3
95.1%
Valuation • Fair Value

Carlsmed Inc (NASDAQ-CARL) Fair Value by Valuation Model

Review the available estimates for Carlsmed Inc (NASDAQ-CARL), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$12.06

Estimated downside of 21.3% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$12.12

Discounted cash flow valuation reference.

EPV Fair Value

$9.38

Earnings power value estimate.

Comps Fair Value

$12.48

Comparable-company valuation reference.

Analyst Price Target

$19.40

Analysts imply upside of 26.6%.

How to read these valuation models

Use the 6 available valuation references for Carlsmed Inc (NASDAQ-CARL) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Carlsmed Inc (NASDAQ-CARL)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

63.295 M

Current operating scale indicator.

Revenue Forecast

76.851 M

Forward revenue estimate.

EBITDA

-38.256 M

Current operating profitability reference.

EBITDA Forecast

-33.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Carlsmed Inc (NASDAQ-CARL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Carlsmed Inc (NASDAQ-CARL)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.37

No elevated caution signal from this screen.

Altman Z-Score

6.3

Relatively strong balance-sheet zone.

FCF / Net Income

95.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Carlsmed Inc (NASDAQ-CARL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Carlsmed Inc (NASDAQ-CARL)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 10, 2026

Days to Earnings

4

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Carlsmed Inc (NASDAQ-CARL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Carlsmed Inc (NASDAQ-CARL) Stock Forecast & Technical Outlook

Review Carlsmed Inc (NASDAQ-CARL) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Carlsmed Inc (NASDAQ-CARL) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Carlsmed Inc (NASDAQ-CARL) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Carlsmed Inc (NASDAQ-CARL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Carlsmed Inc (NASDAQ-CARL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Carlsmed Inc (NASDAQ-CARL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Carlsmed Inc (NASDAQ-CARL)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Carlsmed Inc (NASDAQ-CARL) has a Strong Buy consensus, with 3 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 3
Hold 0
Sell 0
FAQ • Fast Investor Answers

Carlsmed Inc (NASDAQ-CARL) Stock FAQ

Data-supported answers about Carlsmed Inc (NASDAQ-CARL), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$12.06
Estimated downside 21.3%
Valuation Rating
Overvalued
Estimated downside of 21.3%
Analyst Target
$19.40
Implied upside 26.6%
Financial Health
Good
Current financial-health read

The current fair value estimate for Carlsmed Inc (NASDAQ-CARL) is $12.06. This implies an estimated downside of 21.3% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 21.3% versus the current market price.

The available analyst price target for Carlsmed Inc (NASDAQ-CARL) is $19.40. The analyst target implies estimated upside of 26.6%.

The current financial health read for Carlsmed Inc (NASDAQ-CARL) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Carlsmed Inc (NASDAQ-CARL) is November 10, 2026.

The latest available data indicates no current dividend yield for Carlsmed Inc (NASDAQ-CARL).

The current market capitalization listed for Carlsmed Inc is 418.3 M.

The current enterprise value listed for Carlsmed Inc is 351 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Carlsmed Inc is NASDAQ-CARL, and the stock is listed on NASDAQ.

Carlsmed Inc (NASDAQ-CARL) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Carlsmed Inc is 5.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Carlsmed Inc is 57.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 196.7 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 162.4 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 128.3 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 127.6 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 64.704 B
BDX NYSE Becton Dickinson and Co Fair Value Fair Market Cap 58.168 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 57.971 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 52.86 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 52.302 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Fair Market Cap 37.867 B
ALC NYSE Alcon AG Fair Value Fair Market Cap 37.14 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 33.661 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 31.503 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 30.181 B
STE NYSE STERIS plc Fair Value Fair Market Cap 24.777 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 20.222 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.84 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 13.319 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.27 B
GKOS NYSE Glaukos Corp Fair Value Overvalued Market Cap 13.016 B